RevMab

anti-Cytokeratin-18 (human), Rabbit Monoclonal (RM279)

CHF 459.00
In stock
REV-31-1162-00-R100100 µlCHF 459.00
More Information
Product Details
Synonyms CK18; CK-18; Cytokeratin 18
Product Type Recombinant Antibody
Properties
Clone RM279
Isotype Rabbit IgG
Source/Host Rabbit
Immunogen/Antigen A peptide corresponding to the N-terminus of human Cytokeratin-18.
Application

Immunohistochemistry (IHC): 1:1000-1:4000 dilution
Western Blot (WB): 1:1000-1:2000 dilution

Crossreactivity Human
Specificity

This antibody reacts to human CK18 (Cytokeratin-18).

Purity Protein A purified.
Purity Detail Protein A affinity purified from an animal origin-free culture supernatant.
Concentration N/A
Formulation Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide.
Isotype Negative Control

Rabbit IgG

Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Accession Number P05783
Declaration Manufactured by RevMab Biosciences.
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Cytokeratins are keratin proteins found in the intracytoplasmic cytoskeleton of epithelial tissue (at least 20 different polypeptides). They are an important component of intermediate filaments, which help cells resist mechanical stress. Expression of these cytokeratins within epithelial cells is largely specific to particular organs or tissues. The subsets of cytokeratins which an epithelial cell expresses depends mainly on the type of epithelium, the moment in the course of terminal differentiation and the stage of development. Thus a specific cytokeratin expression profile allows the identification of epithelial cells. Furthermore, this applies also to the malignant counterparts of the epithelia, (carcinomas). Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. Cytokeratin-18 (Keratin 18; CK18) belongs to the type A (acidic) subfamily of low molecular weight keratins and exists in combination with cytokeratin-8. Tissues from gastrointestinal tract, respiratory tract and urogenital tract, as well as endocrine and exocrine tissues and mesothelial cells are positive for cytokeratin-18. Further, cytokeratin-18 is found primarily in non-squamous epithelia and is present in a majority of adenocarcinomas and ductal carcinomas, but not in squamous cell carcinomas. Mutations in the cytokeratin-18 gene have been linked to cryptogenic cirrhosis. During apoptosis, keratin filaments are altered and remarkably stable keratin fragments are generated. Activation of caspases leads to proteolysis of numerous cellular proteins, including structural components of epithelial cells. Cytokeratin-18 along with cytokeratin-8 are the major components of intermediate filaments in simple epithelial cells, and the only keratin pair in normal hepatocytes. Cytokeratin-18 is often used to identify differentiated isolated hepatocytes. During apoptosis, cytokeratin-8/cytokeratin-18 fragments are dramatically reorganized and cytokeratin-18 is cleaved by caspases at multiple sequence sites. Cleavage of cytokeratin-18 is an early event occurring during apoptosis.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.